Extreme early-onset hypertension

Gene: CYP11B2

Green List (high evidence)

CYP11B2 (cytochrome P450 family 11 subfamily B member 2)
EnsemblGeneIds (GRCh38): ENSG00000179142
EnsemblGeneIds (GRCh37): ENSG00000179142
OMIM: 124080, Gene2Phenotype
CYP11B2 is in 5 panels

3 reviews

Achchuthan Shanmugasundram (Genomics England Curator)

Green List (high evidence)

Autosomal recessive variants in CYP11B2 causes Hypoaldosteronism, congenital, due to CMO I deficiency (MIM #203400) and due to CMO II deficiency (MIM #610600). Patients with these disorders present with salt loss and failure to thrive in early childhood and they do not present with hypertension.

Glucocorticoid-remediable aldosteronism (GRA, MIM #103900) is an autosomal-dominant disorder caused by chimeric duplication of CYP11B1 and CYP11B2 genes. These patients present with early-onset hypertension. Hence, the MOI in this panel should be 'MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted' rather than 'BIALLELIC, autosomal or pseudoautosomal' as in 'Congenital adrenal hypoplasia' panel.
Created: 6 Mar 2023, 10:42 a.m. | Last Modified: 6 Mar 2023, 3:14 p.m.
Panel Version: 1.21

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Aldosteronism, glucocorticoid-remediable, OMIM:103900; {Low renin hypertension, susceptibility to}; Aldosterone to renin ratio raised

Fiona Karet (Universit y of Cambridge)

Green List (high evidence)

Additional chimeric gene in which the 5-prime regulatory sequences of the CYP11B1 gene is fused to the coding region of the CYP11B2 gene
Created: 20 Jun 2016, 6:14 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Glucucorticoid-remediable hyperaldosteronsim

Publications

Mode of pathogenicity
Other

Variants in this GENE are reported as part of current diagnostic practice

Sarah Leigh (Genomics England Curator)

Comment when marking as ready: Associated with phenotype in OMIM, not G2P. Found in 1/4 sources. One expert reviewer recommends Green.
Created: 3 Aug 2016, 12:57 p.m.
Comment on phenotypes: Biallelic variants reported in Hypoaldosteronism, congenital, due to CMO I deficiency 203400 & Hypoaldosteronism, congenital, due to CMO II deficiency 610600
Created: 3 Aug 2016, 12:32 p.m.
Comment on mode of pathogenicity: Gene fusion between 5' of CYP11B1 gene is fused to the coding region of the CYP11B2 gene results in increased expression
Created: 3 Aug 2016, 12:27 p.m.
Comment on mode of inheritance: For Glucocorticoid-remediable aldosteronism
Created: 3 Aug 2016, 12:23 p.m.

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Radboud University Medical Center, Nijmegen
Phenotypes
  • Aldosteronism, glucocorticoid-remediable, OMIM:103900
  • {Low renin hypertension, susceptibility to}
  • Aldosterone to renin ratio raised
Tags
chimeric-gene
OMIM
124080
Clinvar variants
Variants in CYP11B2
Penetrance
Complete
Publications
Mode of Pathogenicity
Other - please provide details in the comments
Panels with this gene

History Filter Activity

6 Mar 2023, Gel status: 3

Set Phenotypes

Achchuthan Shanmugasundram (Genomics England Curator)

Phenotypes for gene: CYP11B2 were changed from Aldosterone to renin ratio raised, Glucucorticoid-remediable hyperaldosteronsim to Aldosteronism, glucocorticoid-remediable, OMIM:103900; {Low renin hypertension, susceptibility to}; Aldosterone to renin ratio raised

7 Jun 2022, Gel status: 3

Added Tag

Arina Puzriakova (Genomics England Curator)

Tag chimeric-gene tag was added to gene: CYP11B2.

3 Aug 2016, Gel status: 4

panel promoted to version 1

Sarah Leigh (Genomics England Curator)

Promoted 03/08/2016

3 Aug 2016, Gel status: 4

Gene classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

3 Aug 2016, Gel status: 1

Set publications

Sarah Leigh (Genomics England Curator)

Publications for CYP11B2 were set to 1731223; 26309573; 23150505

3 Aug 2016, Gel status: 1

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for CYP11B2 were set to Aldosterone to renin ratio raised, Glucucorticoid-remediable hyperaldosteronsim

3 Aug 2016, Gel status: 1

Set mode of pathogenicity

Sarah Leigh (Genomics England Curator)

Mode of pathogenicity for CYP11B2 was changed to Other - please provide details in the comments

3 Aug 2016, Gel status: 1

Set Mode of Inheritance

Sarah Leigh (Genomics England Curator)

Mode of inheritance for CYP11B2 was changed to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

3 Aug 2016, Gel status: 1

Set publications

Sarah Leigh (Genomics England Curator)

Publications for CYP11B2 were set to 1731223; 26309573

3 Aug 2016, Gel status: 1

Set publications

Sarah Leigh (Genomics England Curator)

Publications for CYP11B2 were set to 1731223

7 Jun 2016, Gel status: 1

Set Mode of Inheritance

Sarah Leigh (Genomics England Curator)

Mode of inheritance for CYP11B2 was changed to BIALLELIC, autosomal or pseudoautosomal

7 Jun 2016, Gel status: 1

Gene classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

This gene has been classified as Red List (Low Evidence).

7 Jun 2016, Gel status: 1

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for CYP11B2 were set to Hypoaldosteronism, congenital, due to CMO II deficiency, 610600

28 Apr 2015, Gel status: 1

Added New Source

GEL ()

CYP11B2 was added to Extreme early-onset hypertensionpanel. Sources: Radboud University Medical Center, Nijmegen